Original Research

Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure

Ballester MR, Roig E, Gich I, Puntes M, Delgadillo J, Santos B, Antonijoan RM

Drug Design, Development and Therapy 2015, 9:4291-4302

Published Date: 5 August 2015